Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Interleukin Genetics Signs Letter of Intent - Nutraceuticals World

What are you searching for?

Sign in
Market Updates

Interleukin Genetics Signs Letter of Intent

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Interleukin Genetics Signs Letter of Intent
Interleukin Genetics (ILGN), Wal­tham, MA, has signed a letter of intent with an undisclosed major consumer products company to develop and market proprietary genomics-based nutritional and skincare products. The two parties have executed a letter of intent that, in exchange for an undisclosed sum, permits the nutrition company a limited period in which to evaluate the option of entering into a joint venture or executing a licensing agreement in the area of nutritional genomics. The arrangement allows ILGN to continue its business development activities for the diagnostic and therapeutic applications of the company’s technology.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters